Clinical Trials Browser

Phase 1/2 × Triple Negative Breast Neoplasms × seviteronel × Clear all

NCT04947189 2025-05-15

4CAST

Phase 1/2 Recruiting

Triple Negative Breast Neoplasms

NCT02580448 2019-02-01

CLARITY-01

Phase 1/2 Completed

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms